ClinicalTrials.gov Compliance Will Improve With Time, PhRMA Suggests
This article was originally published in The Pink Sheet Daily
Executive Summary
Early stats on industry's posting rate should not be seen as evidence of a "widespread breakdown" in the system, PhRMA declares in a letter to Rep. Waxman. PhRMA believes it can reach full compliance – but suggested it may need several years to do it.